aspirin

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

June 9, 2021
British Reporter — The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19. Patients with COVID-19 are at increased risk of blood clots forming in their blood vessels, particularly in the lungs. Between November 2020 and March 2021, the RECOVERY trial included nearly 15,000 patients hospitalised with COVID-19 in

Get updates

Join

We hate spams like you do

Latest comments

Go toTop